|
000
| 02652nam 2200337zi 4500 |
|---|
| 001 | 9.932127 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240311120532 |
|---|
| 006 | m o d f |
|---|
| 007 | cr mn||||||||| |
|---|
| 008 | 240105e201703##oncad ob f|0| 0 eng d |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH14-493/2017E-PDF |
|---|
| 245 | 00|aEvaluation of the Canadian Agency for drugs and technologies in health activities 2012-2013 to 2015-2016 / |cprepared by Office of Audit and Evaluation, Health Canada and the Public Health Agency of Canada. |
|---|
| 264 | 1|a[Ottawa] : |bHealth Canada and the Public Health Agency of Canada = Santé Canada et l'Agence de la santé publique du Canada, |cMarch 2017. |
|---|
| 300 | |a1 online resource (v, 54 pages) : |billustrations, graphs |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aCover title. |
|---|
| 500 | |aIssued also in French under title: Évaluation des activités de l’Agence canadienne des médicaments et des technologies de la santé de 2012-2013 à 2015-2016. |
|---|
| 504 | |aIncludes bibliographical references (pages 52-54). |
|---|
| 520 | |a"This evaluation covered the activities of the Canadian Agency for Drugs and Technologies in Health (CADTH) for the period from 2012-2013 to 2015-2016. The evaluation was undertaken in fulfillment of the requirements of the Financial Administration Act and the Treasury Board of Canada’s Policy on Results (2016) ... The purpose of the evaluation was to assess the relevance and performance of CADTH’s activities. The scope of the evaluation covered various CADTH activities from April 2012 to March 2016, including health technology assessments (HTAs), optimal use projects and common drug reviews (CDR). Where warranted, data outside this timeframe was included in the evaluation"--Executive summary, page ii. |
|---|
| 610 | 20|aCanadian Agency for Drugs and Technologies in Health|xEvaluation. |
|---|
| 710 | 1 |aCanada. |bHealth Canada. |bOffice of Audit and Evaluation, |eissuing body. |
|---|
| 710 | 2 |aPublic Health Agency of Canada. |bOffice of Audit and Evaluation, |eissuing body. |
|---|
| 775 | 08|tÉvaluation des activités de l’Agence canadienne des médicaments et des technologies de la santé de 2012-2013 à 2015-2016 / |w(CaOODSP)9.935144 |
|---|
| 856 | 40|qPDF|s701 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H14-493-2017-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/corporate/transparency/corporate-management-reporting/evaluation/2012-2013-2015-2016-canadian-agency-drugs-technologies.html |
|---|